We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Stenting and Bypass Surgery Offer Same Protection

By HospiMedica staff writers
Posted on 24 Apr 2001
A multisite international study has demonstrated that, after one year, angioplasty with coronary-artery stenting offers the same protection against stroke, heart attack, and death as bypass surgery. More...
Although stenting costs less, it results in the need for a second revascularization more often than bypass surgery. The study, conducted by the Arterial Revascularization Therapies Study Group under the auspices of the European Academy of Sciences and Arts, was published in The New England Journal of Medicine (2001;344;1117-1124).

The study involved 1,205 patients, randomly assigned to have the stent procedure or bypass surgery when a cardiac surgeon and an interventional cardiologist agreed that either procedure would produce the same amount of revascularization. Among patients in the stenting group who survived without a stroke or heart attack, 16.8% needed to have a second revascularization, compared to only 3.5% of patients in the surgery group. After one year, 73.8% of stent patients and 87.8% of surgery patients had an event-free survival. Stenting was estimated to cost about US$3,000 less than surgery.

Because angioplasty with stenting is less invasive than surgery, it is associated with a faster recovery and better quality of life one month later. On the other hand, bypass surgery is associated with a lower incidence of angina in the first year and fewer interventions. The researchers note that doctor and patient need to weigh all these factors in deciding which approach is best.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.